Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jul 1;2(1):122-130.
doi: 10.1089/heq.2018.0002. eCollection 2018.

Sociodemographic Characteristics of Women Able to Obtain Medication Abortion Before and After Ohio's Law Requiring Use of the Food and Drug Administration Protocol

Affiliations

Sociodemographic Characteristics of Women Able to Obtain Medication Abortion Before and After Ohio's Law Requiring Use of the Food and Drug Administration Protocol

Ushma D Upadhyay et al. Health Equity. .

Abstract

Purpose: In 2011, a law went into effect in Ohio that regulates how abortion care providers can offer medication abortion to their patients. We sought to evaluate changes in sociodemographic characteristics of Ohio medication abortion patients before and after the implementation of this law. Methods: We used a retrospective cohort design, comparing characteristics of women obtaining a medication abortion at four abortion facilities before and after the law. We used chart data from January 2010 to January 2011 and February 2011 to October 2014. For any significant changes in sociodemographics found before and after the law, we used stratified cross-tabulations to disentangle whether they were likely related to the restricted gestational limit imposed by the law (lowered from 9 to 7 weeks gestation), or whether they were likely related to other burdens brought on by the law, such as increased costs and visits. Results: Women obtaining a medication abortion after the law were more likely to be older (p=0.01), have higher levels of education (p<0.001), be of white race (p<0.001), have private insurance (p=0.001), have no children (p=0.002), and reside in a higher income zip code (p=0.03). Both the reduced gestational limit and the increased costs and visits likely contributed to declines among black women and women with lower levels of education. The reduced gestational limit for medication abortion likely contributed to a decline among younger women and Medicaid recipient groups. The increased costs and visits imposed by the law likely contributed to the decline in medication abortion among women with no insurance and women with children. Conclusion: The lower gestational limit, higher cost, and time and travel burdens exacted by Ohio's medication abortion law were associated with disproportionate reductions in medication abortion among the most disadvantaged groups. The law was associated with reduced access among women who were younger, of black race, less educated, and in lower socioeconomic groups.

Keywords: Ohio; abortion; health policy; medication abortion; sociodemographic characteristics.

PubMed Disclaimer

Conflict of interest statement

No competing financial interests exist.

Figures

<b>FIG. 1.</b>
FIG. 1.
Medication abortion as a percentage of all abortions in Ohio 2010–2014, study clinic and overall state data. State data from Ohio Department of Health ITOP statistics. ITOP, Induced Termination of Pregnancy.

Similar articles

Cited by

References

    1. Weitz TA, Foster A, Ellertson C, et al. . “Medical” and “surgical” abortion: rethinking the modifiers. Contraception. 2004;69:77–78 - PubMed
    1. Winikoff B, Westhoff C. Fifteen years: looking back and looking forward. Contraception. 2015;92:177–178 - PubMed
    1. Greene MF, Drazen JM. A new label for mifepristone. N Engl J Med. 2016;374:2281–2282 - PubMed
    1. Spitz IM, Bardin CW, Benton L, et al. . Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med. 1998;338:1241–1247 - PubMed
    1. Raymond EG, Shannon C, Weaver MA, et al. . First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic review. Contraception. 2013;87:26–37 - PubMed

LinkOut - more resources